Italian study looks back at 24 years of PRRT for rare adrenal cancers
NCT ID NCT07538791
First seen Apr 22, 2026 · Last updated May 23, 2026 · Updated 2 times
Summary
This study looks back at the medical records of about 210 people with advanced pheochromocytoma or paraganglioma (rare adrenal tumors) who received a treatment called PRRT between 2000 and 2024. The goal is to see how well PRRT controls the disease and how long people live after treatment. The study does not involve new treatments or direct patient participation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARAGANGLIOMAS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Azienda Ospedaliero-Universitaria Policlinico di Modena
Modena, Italy
-
Azienda Ospedaliero-Universitaria di Ferrara
Ferrara, Italy
-
Azienda USL IRCCS di Reggio Emilia
Reggio Emilia, Italy
-
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Milan, Italy
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy
-
Irst Irccs
Meldola, Italy
-
Istituto Europeo di Oncologia
Milan, Italy
-
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale
Naples, Italy
-
Policlinico di Bari
Bari, Italy
-
Università degli Studi di Napoli Federico II
Naples, Italy
Conditions
Explore the condition pages connected to this study.